{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:58:14Z","timestamp":1783486694517,"version":"3.55.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T00:00:00Z","timestamp":1532390400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s12020-018-1686-1","type":"journal-article","created":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T11:34:41Z","timestamp":1532432081000},"page":"432-439","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Effect of timing of levothyroxine administration on the treatment of hypothyroidism: a three-period crossover randomized study"],"prefix":"10.1007","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2762-3139","authenticated-orcid":false,"given":"Marko","family":"Skelin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomo","family":"Lucijani\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana-Marija","family":"Liberati-\u010cizmek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanja Majanovi\u0107","family":"Klobu\u010dar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Lucijani\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lejsa","family":"Jakupovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miro","family":"Bakula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena Vu\u010dak","family":"Lon\u010dar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sre\u010dko","family":"Maru\u0161i\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Mati\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u017deljko","family":"Romi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerka","family":"Dumi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Raheli\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,24]]},"reference":[{"key":"1686_CR1","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1089\/thy.2006.0235","volume":"17","author":"Y Aoki","year":"2007","unstructured":"Y. Aoki, R.M. Belin, R. Clickner, R. Jeffries, L. Phillips, K.R. Mahaffey, Serum, TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002). Thyroid 17, 1211\u20131223 (2007)","journal-title":"Thyroid"},{"key":"1686_CR2","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.ecl.2007.04.008","volume":"36","author":"M Devdhar","year":"2007","unstructured":"M. Devdhar, Y. Ousman, K. Burman, Hypothyroidism. Endocrinol. Metab. Clin. North. Am. 36, 595\u2013615 (2007)","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"key":"1686_CR3","doi-asserted-by":"publisher","first-page":"76","DOI":"10.2174\/1874192401105010076","volume":"5","author":"CV Rizos","year":"2011","unstructured":"C.V. Rizos, M.S. Elisaf, E.N. Liberopoulos, Effects of thyroid dysfunction on lipid profile. Open Cardiovasc. Med. J. 5, 76\u201384 (2011)","journal-title":"Open Cardiovasc. Med. J."},{"key":"1686_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1385\/ENDO:24:1:001","volume":"24","author":"B Biondi","year":"2004","unstructured":"B. Biondi, I. Klein, Hypothyroidism as a risk factor for cardiovascular disease. Endocrine 24, 1\u201313 (2004)","journal-title":"Endocrine"},{"key":"1686_CR5","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.beem.2009.06.006","volume":"23","author":"L Liwanpo","year":"2009","unstructured":"L. Liwanpo, J.M. Hershman, Conditions and drugs interfering with thyroxine absorption. Best. Pract. Res. Clin. Endocrinol. Metab. 23, 781\u2013792 (2009)","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"1686_CR6","doi-asserted-by":"publisher","first-page":"492","DOI":"10.7326\/0003-4819-119-6-199309150-00009","volume":"119","author":"SJ Mandel","year":"1993","unstructured":"S.J. Mandel, G.A. Brent, P.R. Larsen, Levothyroxine therapy in patients with thyroid disease. Ann. Intern. Med. 119, 492\u2013502 (1993)","journal-title":"Ann. Intern. Med."},{"key":"1686_CR7","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.clinthera.2017.01.005","volume":"39","author":"M Skelin","year":"2017","unstructured":"M. Skelin, T. Lucijani\u0107, D. Amid\u017ei\u0107 Klari\u0107, A. Re\u0161i\u0107, M. Bakula, A. Liberati-\u010cizmek, H. Gharib, D. Raheli\u0107, Factors affecting gastrointestinal absorption of levothyroxine: a review. Clin. Ther. 39, 378\u2013403 (2017)","journal-title":"Clin. Ther."},{"key":"1686_CR8","unstructured":"Agency for Medicinal Products and Medical Devices. (2015) Euthyrox 100 mg tablets http:\/\/www.halmed.hr\/upl\/lijekovi\/SPC\/UP-I-530-09-14-01-218.pdf . Accessed 10 January 2017."},{"key":"1686_CR9","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/S0149-2918(01)80109-0","volume":"23","author":"AJ Claxton","year":"2001","unstructured":"A.J. Claxton, J. Cramer, C.A. Pierce, A systematic review of the associations between dose regimens and medication compliance. Clin. Ther. 23, 1296\u20131310 (2001)","journal-title":"Clin. Ther."},{"key":"1686_CR10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2265.2006.02681.x","volume":"66","author":"N Bolk","year":"2007","unstructured":"N. Bolk, T.J. Visser, A. Kalsbeek, R.T. Van Domburg, A. Berghout, Effects of evening vs morning thyroxine ingestion on serum thyroid hormone profiles in hypothyroid patients. Clin. Endocrinol. (Oxf.). 66, 43\u201348 (2007)","journal-title":"Clin. Endocrinol. (Oxf.)."},{"key":"1686_CR11","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.1210\/jc.2009-0860","volume":"94","author":"TG Bach-Huynh","year":"2009","unstructured":"T.G. Bach-Huynh, B. Nayak, J. Loh, S. Soldin, J. Jonklaas, Timing of levothyroxine administration affects serum thyrotropin concentration. J. Clin. Endocrinol. Metab. 94, 3905\u20133912 (2009)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1686_CR12","first-page":"134","volume":"6","author":"S Ala","year":"2015","unstructured":"S. Ala, O. Akha, Z. Kashi, H. Asgari, A. Bahar, N. Sasanpour, Dose administration time from before breakfast to before dinner affect thyroid hormone levels? Casp. J. Intern. Med. 6, 134\u2013140 (2015)","journal-title":"Casp. J. Intern. Med."},{"key":"1686_CR13","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1056\/NEJMoa043903","volume":"17","author":"M Centanni","year":"2006","unstructured":"M. Centanni, L. Gargano, G. Canettieri, N. Viceconti, A. Franchi, G. Delle Fave, B. Annibale, Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis. N. Engl. J. Med. 17, 1787\u20131795 (2006)","journal-title":"N. Engl. J. Med."},{"key":"1686_CR14","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/2261261a0","volume":"226","author":"JG Moore","year":"1970","unstructured":"J.G. Moore, E.Jr Englert, Circadian rhythm of gastric acid secretion in man. Nature 226, 1261\u20131262 (1970)","journal-title":"Nature"},{"key":"1686_CR15","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1089\/thy.1995.5.249","volume":"5","author":"S Benvenga","year":"1995","unstructured":"S. Benvenga, L. Bartolone, S. Squadrito, F. Lo Giudice, F. Trimarchi, Delayed intestinal absorption of levothyroxine. Thyroid 5, 249\u2013253 (1995)","journal-title":"Thyroid"},{"key":"1686_CR16","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1517\/17425247.2014.918101","volume":"11","author":"R Vita","year":"2006","unstructured":"R. Vita, P. Fallahi, A. Antonelli, S. Benvenga, The administration of L-thyroxine as soft gel capsule or liquid solution. Expert. Opin. Drug. Deliv. 11, 1103\u20131111 (2006)","journal-title":"Expert. Opin. Drug. Deliv."},{"key":"1686_CR17","first-page":"451","volume":"18","author":"G Ianiro","year":"2014","unstructured":"G. Ianiro, F. Mangiola, T.A. Di Rienzo, S. Bibb\u00f2, F. Franceschi, A.V. Greco, A. Gasbarrini, Levothyroxine absorption in health and disease, and new therapeutic perspectives. Eur. Rev. Med. Pharmacol. Sci. 18, 451\u2013456 (2014)","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"1686_CR18","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s12020-016-0882-0","volume":"52","author":"AM Formenti","year":"2016","unstructured":"A.M. Formenti, G. Mazziotti, R. Giubbini, A. Giustina, Treatment of hypothyroidism: all that glitters is gold? Endocrine 52, 411\u2013413 (2016)","journal-title":"Endocrine"},{"key":"1686_CR19","doi-asserted-by":"publisher","first-page":"505239","DOI":"10.4061\/2011\/505239","volume":"2011","author":"R Rajput","year":"2011","unstructured":"R. Rajput, S. Chatterjee, M. Rajput, Can levothyroxine be taken as evening dose? Comparative evaluation of morning versus evening dose of levothyroxine in treatment of hypothyroidism. J. Thyroid Res. 2011, 505239 (2011). https:\/\/doi.org\/10.4061\/2011\/505239","journal-title":"J. Thyroid Res."},{"key":"1686_CR20","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3389\/fendo.2018.00118","volume":"9","author":"P Trimboli","year":"2018","unstructured":"P. Trimboli, C. Virili, M. Centanni, L. Giovanella, Thyroxine treatment with softgel capsule formulation: usefulness in hypothyroid patients without malabsorption. Front. Endocrinol. (Lausanne). 9, 118 (2018)","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"1686_CR21","doi-asserted-by":"publisher","first-page":"10331","DOI":"10.3748\/wjg.v20.i30.10331","volume":"20","author":"E Lahner","year":"2014","unstructured":"E. Lahner, C. Virili, M.G. Santaguida, B. Annibale, M. Centanni, Helicobacter pylori infection and drugs malabsorption. World J. Gastroenterol. 20, 10331\u201310337 (2014)","journal-title":"World J. Gastroenterol."},{"key":"1686_CR22","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3389\/fendo.2017.00092","volume":"8","author":"M Cellini","year":"2017","unstructured":"M. Cellini, M.G. Santaguida, C. Virili, S. Capriello, N. Brusca, L. Gargano, M. Centanni, Hashimoto\u2019s thyroiditis and autoimmune gastritis. Front. Endocrinol. (Lausanne). 8, 92 (2017)","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"1686_CR23","doi-asserted-by":"publisher","first-page":"345","DOI":"10.4158\/EP.13.4.345","volume":"13","author":"I Sachmechi","year":"2007","unstructured":"I. Sachmechi, D.M. Reich, M. Aninyei, F. Wibowo, G. Gupta, P.J. Kim, Effect of proton pump inhibitors on serum thyroid-stimulating hormone level in euthyroid patients treated with levothyroxine for hypothyroidism. Endocr. Pract. 13, 345\u2013349 (2007)","journal-title":"Endocr. Pract."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-018-1686-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1686-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1686-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T15:39:11Z","timestamp":1720453151000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-018-1686-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,24]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["1686"],"URL":"https:\/\/doi.org\/10.1007\/s12020-018-1686-1","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,24]]},"assertion":[{"value":"11 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"DR has served as principal investigator or co-investigator in clinical trials of AstraZeneca, Eli Lilly, MSD, Novo Nordisk, Sanofi Aventis, Solvay, and Trophos. He has received honoraria for speaking or advisory board engagements and consulting fees from Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Lifescan\u2013Johnson & Johnson, Novartis, Novo Nordisk, MSD, Merck Sharp & Dohme, Pfizer, Pliva, Roche, Salvus, Sanofi Aventis, and Takeda. MS has recevied honoraria for lectures from Roche. Other co-authors have no conflict of interest. TL has served as principal investigator or co-investigator in clinical trials of Bayer HealthCare AG, Sanofi Aventis, Institut de Recherches Internationales Servier, Zavante Therapeutics, and Novo Nordisk. He has received honoraria for speaking engagements from Boehringer Ingelheim, Eli Lilly, Novo Nordisk, MSD.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}